Alulim Pharma, Inc., an aerosol therapeutics company, emerged with a seasoned team and a robust portfolio of pre-clinical and clinical data, along with existing intellectual property protection. Alulim's proven platform technology allows drugs, both water-soluble and insoluble, to be uniquely and safely deposited throughout the respiratory tract, in contrast to newer and unproven platforms. The key benefits of decreased toxicity and more rapid targeted drug distribution to treat cancers, asthma, organ transplantation and various infections have already been demonstrated...
More...
More...